The prevalence of Parkinson’s disease, which affects millions of people worldwide, is
increasing due to the aging population. In addition to the classic motor symptoms caused by the …

Synucleinophaties are progressive neurodegenerative disorders with no cure to date. An
attractive strategy to tackle this problem is repurposing already tested safe drugs against novel …

Background Gam-COVID-Vac (SPUTNIK V) has been granted emergency use authorization
in 70 nations and has been administered to millions worldwide. However, there are very few …

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative
disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn). …

Aggregated forms of the synaptic protein α-synuclein (αS) have been proposed to operate
as a molecular trigger for microglial inflammatory processes and neurodegeneration in …

When activated, microglial cells have the potential not only to secrete typical proinflammatory
mediators but also to release the neurotransmitter glutamate in amounts that may promote …

Curcumin (CUR) is a bioactive compound that has been proposed for the treatment of
various neurodegenerative diseases. However, its use is limited due to its low solubility in …

Neurodegenerative diseases are chronic and progressive disorders that affect specific regions
of the brain, causing gradual disability and suffering that results in a complete inability of …

The stability of a lentil lectin, an all-β protein, has been perturbed by changes in pH and
temperature. In the pH interval 5.0 → 10.0, the overall secondary structure does not undergo …

Tauopathies are neurodegenerative disorders with increasing incidence and still without
cure. The extensive time required for development and approval of novel therapeutics …